1. Said, Rahma, Bougatef, Karim, Setti Boubaker, Nouha, Chebil, Mohamed, Ouerhani, Slah. 2018. Polymorphisms in XPC gene and risk for prostate cancer. In Molecular biology reports, 46, 1117-1125. doi:10.1007/s11033-018-4572-2. https://pubmed.ncbi.nlm.nih.gov/30552616/
2. Zou, Yan-Feng, Tao, Jin-Hui, Ye, Qian-Ling, Su, Hong, Ye, Dong-Qing. 2013. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects. In Genetic testing and molecular biomarkers, 17, 926-31. doi:10.1089/gtmb.2013.0267. https://pubmed.ncbi.nlm.nih.gov/24093803/
3. Ijaz, Ambreen, Basit, Sulman, Gul, Ajab, Ahmad, Jamil, Wali, Abdul. 2018. XPC gene mutations in families with xeroderma pigmentosum from Pakistan; prevalent founder effect. In Congenital anomalies, 59, 18-21. doi:10.1111/cga.12281. https://pubmed.ncbi.nlm.nih.gov/29569758/
4. Lakkireddy, Samyuktha, Aula, Sangeetha, Kapley, Atya, Kutala, Vijay Kumar, Jamil, Kaiser. 2021. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population. In The journal of gene medicine, 23, e3339. doi:10.1002/jgm.3339. https://pubmed.ncbi.nlm.nih.gov/33829606/